Reference SummaryRudolph-Owen LA, Cancer Res 1998 Dec 1;58(23):5500-6
Title |
The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. | ||||
Authors |
Rudolph-Owen LA; Chan R; Muller WJ; Matrisian LM | ||||
Journal |
Cancer Res | ||||
Volume |
58 | ||||
Issue |
23 | ||||
Year |
1998 | ||||
Pages |
5500-6 | ||||
Abstract |
Overexpression of the epithelial specific matrix metalloproteinase matrilysin (MAT) has been correlated with enhanced tumorigenicity and tumor cell invasion using in vitro model systems. We have determined the effects of MAT expression on the development of mammary tumorigenesis using transgenic mice that express human MAT under the control of the mouse mammary tumor virus (MMTV)-long terminal repeat promoter/enhancer. Examination of mammary glands from multiparous MMTV-MAT animals revealed the development of premalignant hyperplastic alveolar nodules in 50% of aged females. MMTV-MAT mice were mated with MMTV-neu transgenic mice to determine the effect of MAT on neu-induced mammary tumorigenesis. Bigenic MMTV-MAT/neu female offspring developed primary mammary tumors approximately 13 weeks earlier than did MMTV-neu controls. The mechanism of enhanced neu-induced tumorigenesis was explored. No discernible difference in Neu receptor dimerization or activation was detected in MMTV-MAT/neu tumors or mammary glands compared to MMTV-neu controls. A similar percentage of MMTV-MAT/neu and MMTV-neu tumors acquired deletions in the neu transgene, which have previously been shown to result in constitutive receptor activation. The presence of premalignant nodules and the accelerated development of oncogene-induced mammary tumors suggest that expression of MAT in the mammary epithelium contributes to early-stage mammary tumorigenesis. | ||||
Links |
J:51367 – MGI References 9850086 – National Library of Medicine/PubMed |
||||
Strain Notes
|
|||||
| Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
|---|---|---|---|---|---|
| FVB/N-Tg(MMTVneu)202Mul | Mammary gland adenocarcinoma | Mammary gland |
50 - 79 |
||
| FVB/N-Tg(MMTV-MAT)3Lmm Tg(MMTVneu)202Mul | Mammary gland adenocarcinoma | Mammary gland |
50 - 100 |
||
| FVB/N-Tg(MMTV-MAT)3Lmm | Mammary gland hyperplasia | Mammary gland |
50 |
||
| FVB/N | Mammary gland hyperplasia | Mammary gland |
0 |
||
| FVB/N-Tg(MMTV-MAT)3Lmm | Mammary gland tumor | Mammary gland |
0 |